Slimming Down the Options: A Prescriber’s Guide to Antiobesity Medications

June 5, 2025

Target Audience

TBA

Learning Objectives

  1. Identify, evaluate, and assess appropriate patients for treatment with antiobesity medications (AOM).
  2. Compare and differentiate AOMs used to treat obesity.
  3. Educate patients regarding obesity treatment selection.
  4. Explain the prior authorization process for AOM.
  5. Describe limitations concerning active-duty service members (ADSM) use of AOMs.
Course summary
Available credit: 
  • 1.00 ACCME Non-Physician CME Credit
    DHA, J-7, CEPO is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing education. ACCME Non-Physician CME Credit providers will be provided a certificate of participation for educational activities certified for AMA PRA Category 1 Credit™. ACCME Non-Physician CME Credit providers may receive a maximum of 1.00 hours for completing this Course activity.
  • 1.00 Physicians (ACCME)

    DHA, J-7, CEPO is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    DHA, J-7, CEPO designated this Course for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • 1.00 Certificate of Attendance
  • 1.00 Interprofessional Continuing Education (IPCE)

    In support of improving patient care, DHA, J-7, CEPO is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the health care team. This activity was planned by and for the healthcare team, and learners will receive 1.00 Interprofessional Continuing Education (IPCE) credits for learning and change.

Course opens: 
05/05/2025
Course expires: 
06/19/2025
Event starts: 
06/05/2025 - 8:15am EDT
Event ends: 
06/05/2025 - 9:15am EDT
Part of: 
2025 JUN CCSS: Evidence-Based Approaches for Advancing Excellence in Primary Care
Add to calendar: 

MS Teams Link: TBA

Disclosure: 
Presenter will discuss off-label use for the following medications: metformin, topiramate, lisdexamfetamine, bupropion, naltrexone, zonasimide, dulaglutide, liraglutide, semaglutide, tirzepitide, exantide, pramlintide, canagliflozin, dapagliflozin, and empagliflozin.

DHA J-7 staff, planners, authors, and content reviewers for this educational activity have no relevant financial relationship(s) with ineligible companies to disclose.

Speaker(s)

Brittany Howard, PA-C, ASMBS

has no relevant financial relationships to disclose at this time.

TBA

Available Credit

  • 1.00 ACCME Non-Physician CME Credit
    DHA, J-7, CEPO is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing education. ACCME Non-Physician CME Credit providers will be provided a certificate of participation for educational activities certified for AMA PRA Category 1 Credit™. ACCME Non-Physician CME Credit providers may receive a maximum of 1.00 hours for completing this Course activity.
  • 1.00 Physicians (ACCME)

    DHA, J-7, CEPO is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    DHA, J-7, CEPO designated this Course for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • 1.00 Certificate of Attendance
  • 1.00 Interprofessional Continuing Education (IPCE)

    In support of improving patient care, DHA, J-7, CEPO is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the health care team. This activity was planned by and for the healthcare team, and learners will receive 1.00 Interprofessional Continuing Education (IPCE) credits for learning and change.

Please login or create an account to take this course.



Requirements: CE/CME certificates are awarded to participants who fully complete the activity, successfully submit the evaluation survey, and pass the posttest. The deadline to claim credit is Jun 19, 2025.

Access Code: Some activities require an access code to register or claim credit. Please contact the organization providing the activity for the access code. The Continuing Education Program Office (CEPO) does not provide access codes.

Accommodations: Please contact the course instructor to inquire about accommodations. For additional technical support, email [email protected].